These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1522486)

  • 1. Quantitative prediction of transdermal iontophoretic delivery of arbutamine in humans with the in vitro isolated perfused porcine skin flap.
    Riviere JE; Williams PL; Hillman RS; Mishky LM
    J Pharm Sci; 1992 Jun; 81(6):504-7. PubMed ID: 1522486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vasoactive drugs on transdermal lidocaine iontophoresis.
    Riviere JE; Sage B; Williams PL
    J Pharm Sci; 1991 Jul; 80(7):615-20. PubMed ID: 1941556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH): effect of repeated administration.
    Heit MC; Monteiro-Riviere NA; Jayes FL; Riviere JE
    Pharm Res; 1994 Jul; 11(7):1000-3. PubMed ID: 7937539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive delivery of a novel inotropic catecholamine: iontophoretic versus intravenous infusion in dogs.
    Sanderson JE; Caldwell RW; Hsiao J; Dixon R; Tuttle RR
    J Pharm Sci; 1987 Mar; 76(3):215-8. PubMed ID: 3585737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model describing transdermal iontophoretic delivery of lidocaine incorporating consideration of cutaneous microvascular state.
    Williams PL; Riviere JE
    J Pharm Sci; 1993 Nov; 82(11):1080-4. PubMed ID: 8289117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap.
    Williams PL; Riviere JE
    J Pharm Sci; 1989 Jul; 78(7):550-5. PubMed ID: 2674404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoretic peptide delivery: in vitro and in vivo studies with luteinizing hormone releasing hormone.
    Heit MC; Williams PL; Jayes FL; Chang SK; Riviere JE
    J Pharm Sci; 1993 May; 82(5):240-3. PubMed ID: 8360818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of penetrant and vehicle mixture properties on transdermal permeability using a mixed effect pharmacokinetic model of ex vivo porcine skin.
    Chittenden JT; Riviere JE
    Biopharm Drug Dispos; 2016 Oct; 37(7):387-396. PubMed ID: 27246159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmental modeling of transdermal iontophoretic transport II: in vivo model derivation and application.
    Nugroho AK; Della-Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2005 Mar; 22(3):335-46. PubMed ID: 15835738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
    Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
    Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M
    J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic modulation of the cutaneous vasculature in the isolated perfused porcine skin flap.
    Rogers RA; Riviere JE
    J Pharm Sci; 1994 Dec; 83(12):1682-9. PubMed ID: 7891294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiologically relevant pharmacokinetic model of xenobiotic percutaneous absorption utilizing the isolated perfused porcine skin flap.
    Williams PL; Carver MP; Riviere JE
    J Pharm Sci; 1990 Apr; 79(4):305-11. PubMed ID: 2352140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology.
    Riviere JE; Monteiro-Riviere NA
    Crit Rev Toxicol; 1991; 21(5):329-44. PubMed ID: 1741948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolated perfused porcine skin flap. III. Percutaneous absorption pharmacokinetics of organophosphates, steroids, benzoic acid, and caffeine.
    Carver MP; Williams PL; Riviere JE
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):324-37. PubMed ID: 2922763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal Delivery of Etoposide Phosphate I: In Vitro and In Vivo Evaluation.
    Patel H; Joshi A; Joshi A; Stagni G
    J Pharm Sci; 2016 Jul; 105(7):2114-22. PubMed ID: 27233689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.